← Leaderboards
William Douglas Figg
Division Of Basic Sciences - Nci
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Laboratories”
- David Heimbrook · Leidos Biomedical Research, Inc.$943,075,715
- Lawrence Corey · Fred Hutchinson Cancer Center$747,603,944
- Jeffrey P Krischer · University Of South Florida$627,303,958
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$553,634,937
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$463,311,620
Research focus
LaboratoriesPharmaceutical PreparationsAntineoplastic AgentsMalignant Neoplasm Of ProstateDoseInterestToxic EffectBaseDrug KineticsBiologicalDocetaxelResponseDrug DevelopmentClinical TrialsTissuesMolecularChemotherapyCancer TherapyGenesCollaborationsInhibitor/AntagonistSamplingMediatingMalignant Neoplasms
Grant awards (127)
Biospecimen Processing and Biorepository$2,211,062
ZIC · FY2025 · CA · contact PI
Using Clinical Pharmacology Principles to Develop New Anticancer Therapies$1,799,703
ZIC · FY2025 · CA · contact PI
Clinical Pharmacogenetics$1,028,401
ZIA · FY2025 · CA · contact PI
Drug Development for Prostate Cancer$782,938
ZIA · FY2025 · CA · contact PI
Development of Anticancer Agents$587,204
ZIA · FY2025 · CA · contact PI
Genetics and Molecular Mechanisms of Prostate Cancer$587,204
ZIA · FY2025 · CA · contact PI
Clinical Pharmacology and Drug-Drug Interactions in HIV-Associated Malignancy$102,841
ZIA · FY2025 · CA · contact PI
Using Clinical Pharmacology Principles to Develop New Anticancer Therapies$1,674,018
ZIC · FY2024 · CA · contact PI
Biospecimen Processing and Biorepository$1,674,018
ZIC · FY2024 · CA · contact PI
Drug Development for Prostate Cancer and other Metastatic Processes$1,014,238
ZIA · FY2024 · CA · contact PI
Clinical Pharmacogenetics$956,582
ZIA · FY2024 · CA · contact PI
Development of Anticancer Agents$760,679
ZIA · FY2024 · CA · contact PI
Genetics and Molecular Mechanisms of Prostate Cancer$760,679
ZIA · FY2024 · CA · contact PI
Clinical Pharmacology and Drug-Drug Interactions in HIV-Associated Malignancy$478,291
ZIA · FY2024 · CA · contact PI
Using Clinical Pharmacology Principles to Develop New Anticancer Therapies$1,692,241
ZIC · FY2023 · CA · contact PI
Biospecimen Processing and Biorepository$1,692,241
ZIC · FY2023 · CA · contact PI
Drug Development for Prostate Cancer and other Metastatic Processes$1,046,884
ZIA · FY2023 · CA · contact PI
Clinical Pharmacogenetics$966,995
ZIA · FY2023 · CA · contact PI
Development of Anticancer Agents$785,162
ZIA · FY2023 · CA · contact PI
Genetics and Molecular Mechanisms of Prostate Cancer$785,162
ZIA · FY2023 · CA · contact PI
Clinical Pharmacology and Drug-Drug Interactions in HIV-Associated Malignancy$683,497
ZIA · FY2023 · CA · contact PI
Using Clinical Pharmacology Principles to Develop New Anticancer Therapies$1,537,766
ZIC · FY2022 · CA · contact PI
Biospecimen Processing and Biorepository$1,537,766
ZIC · FY2022 · CA · contact PI
Drug Development for Prostate Cancer and other Metastatic Processes$973,508
ZIA · FY2022 · CA · contact PI
Clinical Pharmacogenetics$878,724
ZIA · FY2022 · CA · contact PI
Development of Anticancer Agents$730,131
ZIA · FY2022 · CA · contact PI
Genetics and Molecular Mechanisms of Prostate Cancer$730,131
ZIA · FY2022 · CA · contact PI
Clinical Pharmacology and Drug-Drug Interactions in HIV-Associated Malignancy$439,362
ZIA · FY2022 · CA · contact PI
Biospecimen Processing and Biorepository$1,290,557
ZIC · FY2021 · CA · contact PI
Using Clinical Pharmacology Principles to Develop New Anticancer Therapies$1,290,557
ZIC · FY2021 · CA · contact PI
Drug Development for Prostate Cancer and other Metastatic Processes$784,504
ZIA · FY2021 · CA · contact PI
Clinical Pharmacogenetics$759,152
ZIA · FY2021 · CA · contact PI
Development of Angiogenesis Inhibitors$588,377
ZIA · FY2021 · CA · contact PI
Genetics and Molecular Mechanisms of Prostate Cancer$588,377
ZIA · FY2021 · CA · contact PI
Clinical Pharmacology Drug-Drug Interactions in HIV-Associated Malignancy$379,576
ZIA · FY2021 · CA · contact PI
COVID-19 Genetics and Drug Development$75,915
ZIA · FY2021 · CA · contact PI
Biospecimen Processing and Biorepository$1,527,319
ZIC · FY2020 · CA · contact PI
Using Clinical Pharmacology Principles to Develop New Anticancer Therapies$887,976
ZIC · FY2020 · CA · contact PI
Clinical Pharmacogenetics$710,381
ZIA · FY2020 · CA · contact PI
Drug Development for Prostate Cancer and other Metastatic Processes$624,197
ZIA · FY2020 · CA · contact PI
Genetics and Molecular Mechanisms of Prostate Cancer$468,148
ZIA · FY2020 · CA · contact PI
Development of Angiogenesis Inhibitors$468,148
ZIA · FY2020 · CA · contact PI
Clinical Pharmacology Drug-Drug Interactions in HIV-Associated Malignancy$355,191
ZIA · FY2020 · CA · contact PI
COVID-19 Genetics and Drug Development$71,038
ZIA · FY2020 · CA · contact PI
Using Clinical Pharmacology Principles to Develop New Anticancer Therapies$1,676,361
ZIC · FY2019 · CA · contact PI
Biospecimen Processing and Biorepository$1,257,271
ZIC · FY2019 · CA · contact PI
Clinical Pharmacogenetics$1,257,271
ZIA · FY2019 · CA · contact PI
Drug Development for Prostate Cancer and other Metastatic Processes$676,338
ZIA · FY2019 · CA · contact PI
Development of Angiogenesis Inhibitors$507,254
ZIA · FY2019 · CA · contact PI
Genetics and Molecular Mechanisms of Prostate Cancer$507,254
ZIA · FY2019 · CA · contact PI
Biospecimen Processing Biorepository$1,032,433
ZIC · FY2018 · CA · contact PI
Using Clinical Pharmacology Principles to Develop New Anticancer Therapies$1,032,433
ZIC · FY2018 · CA · contact PI
Clinical Pharmacogenetics$1,032,433
ZIA · FY2018 · CA · contact PI
Drug Development for Prostate Cancer and other Metastatic Processes$602,934
ZIA · FY2018 · CA · contact PI
Development of Angiogenesis Inhibitors$452,200
ZIA · FY2018 · CA · contact PI
Genetics Molecular Mechanisms of Prostate Cancer$452,200
ZIA · FY2018 · CA · contact PI
Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents$344,144
ZIC · FY2018 · CA · contact PI
Clinical Pharmacogenetics$1,027,532
ZIA · FY2017 · CA · contact PI
Sample Processing and Analytical Methods Development for New Anticancer Agents$1,027,532
ZIC · FY2017 · CA · contact PI
Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents$685,021
ZIC · FY2017 · CA · contact PI
Using Clinical Pharmacology Principles to Develop New Anticancer Therapies$685,021
ZIC · FY2017 · CA · contact PI
Identify SNPs and Polymorphisms Involved in the Development of Prostate Cancer$546,985
ZIA · FY2017 · CA · contact PI
Development of Angiogenesis Inhibitors$410,239
ZIA · FY2017 · CA · contact PI
Development of Drugs That Target Prostate Cancer$410,239
ZIA · FY2017 · CA · contact PI
Clinical Pharmacogenetics$755,672
ZIA · FY2016 · CA · contact PI
Sample Processing and Analytical Methods Development for New Anticancer Agents$755,672
ZIC · FY2016 · CA · contact PI
Identify SNPs and Polymorphisms Involved in the Development of Prostate Cancer$642,672
ZIA · FY2016 · CA · contact PI
Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents$503,782
ZIC · FY2016 · CA · contact PI
Using Clinical Pharmacology Principles to Develop New Anticancer Therapies$503,782
ZIC · FY2016 · CA · contact PI
Development of Angiogenesis Inhibitors$482,004
ZIA · FY2016 · CA · contact PI
Development of Drugs That Target Prostate Cancer$482,004
ZIA · FY2016 · CA · contact PI
Clinical Pharmacogenetics$719,430
ZIA · FY2015 · CA · contact PI
Sample Processing and Analytical Methods Development for New Anticancer Agents$719,430
ZIC · FY2015 · CA · contact PI
Identify SNPs and Polymorphisms Involved in the Development of Prostate Cancer$600,290
ZIA · FY2015 · CA · contact PI
Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents$479,619
ZIC · FY2015 · CA · contact PI
Using Clinical Pharmacology Principles to Develop New Anticancer Therapies$479,619
ZIC · FY2015 · CA · contact PI
Development of Angiogenesis Inhibitors$450,217
ZIA · FY2015 · CA · contact PI
Development of Drugs That Target Prostate Cancer$450,217
ZIA · FY2015 · CA · contact PI
Sample Processing and Analytical Methods Development for New Anticancer Agents$790,209
ZIC · FY2014 · CA · contact PI
Clinical Pharmacogenetics$790,209
ZIA · FY2014 · CA · contact PI
Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents$790,209
ZIC · FY2014 · CA · contact PI
Identify SNPs and Polymorphisms Involved in the Development of Prostate Cancer$774,152
ZIA · FY2014 · CA · contact PI
Development of Angiogenesis Inhibitors$580,614
ZIA · FY2014 · CA · contact PI
Development of Drugs That Target Prostate Cancer$580,614
ZIA · FY2014 · CA · contact PI
Using Clinical Pharmacology Principles to Develop New Anticancer Therapies$263,403
ZIC · FY2014 · CA · contact PI
Sample Processing and Analytical Methods Development for New Anticancer Agents$678,469
ZIC · FY2013 · CA · contact PI
Clinical Pharmacogenetics$678,469
ZIA · FY2013 · CA · contact PI
Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents$678,469
ZIC · FY2013 · CA · contact PI
Identify SNPs and Polymorphisms Involved in the Development of Prostate Cancer$645,460
ZIA · FY2013 · CA · contact PI
Development of Angiogenesis Inhibitors$484,095
ZIA · FY2013 · CA · contact PI
Development of Drugs That Target Prostate Cancer$484,095
ZIA · FY2013 · CA · contact PI
Using Clinical Pharmacology Principles to Develop New Anticancer Therapies$226,156
ZIC · FY2013 · CA · contact PI
Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents$618,723
ZIC · FY2012 · CA · contact PI
Sample Processing and Analytical Methods Development for New Anticancer Agents$618,723
ZIC · FY2012 · CA · contact PI
Clinical Pharmacogenetics$618,723
ZIA · FY2012 · CA · contact PI
Identify SNPs and Polymorphisms Involved in the Development of Prostate Cancer$587,022
ZIA · FY2012 · CA · contact PI
Development of Angiogenesis Inhibitors$440,267
ZIA · FY2012 · CA · contact PI
Development of Drugs That Target Prostate Cancer$440,267
ZIA · FY2012 · CA · contact PI
Using Clinical Pharmacology Principles to Develop New Anticancer Therapies$206,241
ZIC · FY2012 · CA · contact PI
Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents$595,171
ZIC · FY2011 · CA · contact PI
Clinical Pharmacogenetics$595,171
ZIA · FY2011 · CA · contact PI
Identify SNPs and Polymorphisms Involved in the Development of Prostate Cancer$595,171
ZIA · FY2011 · CA · contact PI
Sample Processing and Analytical Methods Development for New Anticancer Agents$446,379
ZIC · FY2011 · CA · contact PI
Development of Drugs That Target Prostate Cancer$297,586
ZIA · FY2011 · CA · contact PI
Development of Angiogenesis Inhibitors$297,586
ZIA · FY2011 · CA · contact PI
Using Clinical Pharmacology Principles to Develop New Anticancer Therapies$148,793
ZIC · FY2011 · CA · contact PI
Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents$579,624
ZIC · FY2010 · CA · contact PI
Clinical Pharmacogenetics$579,624
ZIA · FY2010 · CA · contact PI
Identify SNPs and Polymorphisms Involved in the Development of Prostate Cancer$579,624
ZIA · FY2010 · CA · contact PI
Sample Processing and Analytical Methods Development for New Anticancer Agents$434,718
ZIC · FY2010 · CA · contact PI
Development of Angiogenesis Inhibitors$289,812
ZIA · FY2010 · CA · contact PI
Development of Drugs That Target Prostate Cancer$289,812
ZIA · FY2010 · CA · contact PI
Using Clinical Pharmacology Principles to Develop New Anticancer Therapies$144,905
ZIC · FY2010 · CA · contact PI
Clinical Pharmacogenetics$594,718
ZIA · FY2009 · CA · contact PI
Identify SNPs and Polymorphisms Involved in the Development of Prostate Cancer$594,718
ZIA · FY2009 · CA · contact PI
Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents$594,718
ZIC · FY2009 · CA · contact PI
Sample Processing and Analytical Methods Development for New Anticancer Agents$446,039
ZIC · FY2009 · CA · contact PI
Development of Drugs That Target Prostate Cancer$297,359
ZIA · FY2009 · CA · contact PI
Development of Angiogenesis Inhibitors$297,359
ZIA · FY2009 · CA · contact PI
Using Clinical Pharmacology Principles to Develop New Anticancer Therapies$148,680
ZIC · FY2009 · CA · contact PI
Clinical Pharmacogenetics$582,605
Z01 · FY2008 · CA · contact PI
Identify SNPs and Polymorphisms Involved in the Development of Prostate Cancer$582,605
Z01 · FY2008 · CA · contact PI
Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents$582,605
Z01 · FY2008 · CA · contact PI
Sample Processing and Analytical Methods Development for New Anticancer Agents$436,954
Z01 · FY2008 · CA · contact PI
Development of Drugs That Target Prostate Cancer$291,303
Z01 · FY2008 · CA · contact PI
Development of Angiogenesis Inhibitors$291,303
Z01 · FY2008 · CA · contact PI
Using Clinical Pharmacology Principles to Develop New Anticancer Therapies$145,651
Z01 · FY2008 · CA · contact PI